BACKGROUND For people with localised prostate cancer, active treatments are effective but
have significant side effects. Minimally invasive treatments that destroy (or ablate) either the …

Background Stereotactic body radiation therapy (SBRT) delivers fewer high-dose fractions of
radiation which may be radiobiologically favorable to conventional low-dose fractions …

BACKGROUND: Focal therapy (FT) for prostate cancer (PCa) seems to be part of a natural
evolution in the quest to improve the management of early organ-confined disease …

Background Localized prostate cancer is a slow growing tumor for many years for the
majority of affected men. Low‐dose rate brachytherapy (LDR‐BT) is short‐distance …

Purpose Under-diagnosed and uncontrolled symptoms in patients with prostate cancer
during radiotherapy can have a negative impact on the individual's quality of life. An …

Brachytherapy for prostate cancer has many good effects, but is also associated, like every
treatment, with side‐effects, some of which have been previously reported in the BJU …

Introduction Erectile dysfunction (ED) is a common adverse event associated with treatment
for prostate cancer. This study aimed to identify whether early, regular use of sildenafil after …

Longterm toxicity and quality of life up to 10 years after lowdose rate brachytherapy for
prostate cancer Page 1 BJUIBJU INTERNATIONAL © 2011 THE AUTHORS 994 BJU …

Purpose To compare 10-year treatment outcomes of brachytherapy vs. external beam
radiation therapy for patients with intermediate-risk prostate cancer (IRPC). Methods and …

Monte Carlo simulation experiments have shown that very high energy electrons (VHEE),
150-250 MeV, have potential advantages in prostate cancer treatment over currently …